Veru Inc. to Participate in Upcoming Financial Conferences
Sep 05, 2017 12:30 pm UTC| Business
MIAMI, Sept. 05, 2017 -- Veru Inc. (Nasdaq:VERU) (formerly, Nasdaq:FHCO) (”Veru” or the “company”), a biopharmaceutical company focused on urology and oncology, today announces that it will participate in two upcoming...
UroGen Pharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Sep 05, 2017 12:30 pm UTC| Business
RAANANA, Israel, and NEW YORK, Sept. 05, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...
Onconova Therapeutics to Participate in Two Investor Conferences in September
Sep 05, 2017 12:30 pm UTC| Business
NEWTOWN, Pa., Sept. 05, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on...
Sonendo® to Present at the Baird 2017 Global Health Conference
Sep 05, 2017 12:30 pm UTC| Business
LAGUNA HILLS, Calif., Sept. 05, 2017 -- Sonendo®, Inc., the developer of a breakthrough technology for the dental marketplace, the GentleWave® System, today announced that Bjarne Bergheim, the Company’s President, and...
Sep 05, 2017 12:30 pm UTC| Business
RALEIGH, N.C., Sept. 05, 2017 -- West Town Bancorp, Inc. (OTC PINK:WTWB) (“West Town”), announced today the successful completion of its acquisition of Sound Banking Company of Morehead City, NC (“Sound Bank”) thereby...
Franklin Templeton Debuts Two New Municipal Bond ETFs
Sep 05, 2017 12:30 pm UTC| Business
SAN MATEO, Calif., Sept. 05, 2017 -- Franklin Templeton Investments today announced the addition of two new actively managed municipal bond ETFs to its Franklin LibertyShares™ lineup for US investors—Franklin Liberty...
Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:30 pm UTC| Business
SOLANA BEACH, Calif., Sept. 05, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it will be featured as a...